Cargando…
Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats
The peptide HsTX1[R14A] is a potent and selective blocker of the voltage-gated potassium channel Kv1.3, which is a highly promising target for the treatment of autoimmune diseases and other conditions. In order to assess the biodistribution of this peptide, it was conjugated with NOTA and radiolabel...
Autores principales: | Bergmann, Ralf, Kubeil, Manja, Zarschler, Kristof, Chhabra, Sandeep, Tajhya, Rajeev B., Beeton, Christine, Pennington, Michael W., Bachmann, Michael, Norton, Raymond S., Stephan, Holger |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473807/ https://www.ncbi.nlm.nih.gov/pubmed/28623364 http://dx.doi.org/10.1038/s41598-017-03998-x |
Ejemplares similares
-
A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases
por: Rashid, M. Harunur, et al.
Publicado: (2014) -
Peripheral Administration of the Kv1.3-Blocking Peptide HsTX1[R14A] Improves Cognitive Performance in Senescence Accelerated SAMP8 Mice
por: Pan, Yijun, et al.
Publicado: (2023) -
Development of Highly Selective Kv1.3-Blocking Peptides Based on the Sea Anemone Peptide ShK
por: Pennington, Michael W., et al.
Publicado: (2015) -
A Potent and Selective Peptide Blocker of the Kv1.3 Channel: Prediction from Free-Energy Simulations and Experimental Confirmation
por: Rashid, M. Harunur, et al.
Publicado: (2013) -
Scorpion venom peptide HsTx2 suppressed PTZ-induced seizures in mice via the circ_0001293/miR-8114/TGF-β2 axis
por: Hu, Yan, et al.
Publicado: (2022)